A new glaucoma surgery: Preserflo versus trabeculectomy
Part of Eyes & vision clinical trials.
This trial compares two types of glaucoma surgery to see which one works better for people with specific kinds of open-angle glaucoma whose eye pressure isn't controlled by eye drops or laser.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 22 years old.
- You have primary open-angle glaucoma, normal-tension glaucoma, pigment-dispersion glaucoma, or pseudoexfoliative glaucoma.
- Your glaucoma is not well controlled with the strongest medications you can take.
- Your visual field test (MD) shows at least -3 decibels of damage.
- Your eye pressure is between 14 and 28 mmHg.
- You have at least 1000 endothelial cells per square millimeter in your cornea.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different tiny drainage devices (a gel stent and a microshunt) for lowering eye pressure in people with certain types of glaucoma that are not well controlled with medications. The goal is to see which device works better and is safer.
This trial tests a tiny implant called Preserflo to treat glaucoma (high eye pressure) that hasn't been controlled with eyedrops. The surgery aims to lower pressure safely while avoiding complications like pressure that drops too low.
This trial is testing a small device called the PRESERFLO MicroShunt to lower eye pressure in people with open-angle glaucoma. It may be an option if your eye pressure stays high even with maximum eye drops.
This trial studies outcomes after certain minimally invasive glaucoma surgeries, including the Preserflo microshunt. It may help improve how safely and effectively glaucoma surgery is done, and how patients are followed afterward.
This trial compares two types of glaucoma surgery—trabeculectomy versus a different procedure that also opens the drainage angle—for people with advanced primary angle-closure glaucoma. It aims to see which surgery controls eye pressure and preserves vision better.
This trial tests two small drainage devices (PreserFlo and XEN stents) for glaucoma, sometimes with an amniotic membrane. The goal is to see which approach is safer and more effective at lowering eye pressure.
Hear when a new GLAUCOMA 1, OPEN ANGLE, D (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.